Abstract
Atopic dermatitis is a common allergic skin disease characterized by eczematous lesions and pruritus. Experimental animal models are essential tools to study the underlying pathogenic mechanisms of atopic dermatitis. This chapter describes a mouse model with spontaneous manifestation of atopic dermatitis-like skin lesions (NC/Nga mice) and a protein-induced mouse model of atopic dermatitis (ovalbumin model) and discusses the role of the histamine receptor (HR) H1R and H4R antagonists in these models.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Spergel JM, Paller AS (2003) Atopic dermatitis and the atopic march. J Allergy Clin Immunol 112(6 Suppl):S118–S127
Hillier A, Griffin CE (2001) The ACVD task force on canine atopic dermatitis (I): incidence and prevalence. Vet Immunol Immunopathol 81:147–151
Gutermuth J, Ollert M, Ring J et al (2004) Mouse models of atopic eczema critically evaluated. Int Arch Allergy Immunol 135:262–276
Matsumoto M, Ra C, Kawamoto K et al (1999) IgE hyperproduction through enhanced tyrosine phosphorylation of Janus kinase 3 in NC/Nga mice, a model for human atopic dermatitis. J Immunol 162:1056–1063
Segawa S, Hayashi A, Nakakita Y et al (2008) Oral administration of heat-killed Lactobacillus brevis SBC8803 ameliorates the development of dermatitis and inhibits immunoglobulin E production in atopic dermatitis model NC/Nga mice. Biol Pharm Bull 31:884–889
Ohsawa Y, Hirasawa N (2012) The antagonism of histamine H1 and H4 receptors ameliorates chronic allergic dermatitis via anti-pruritic and anti-inflammatory effects in NC/Nga mice. Allergy 67:1014–1022
Murota H, El-latif MA, Tamura T et al (2010) Olopatadine hydrochloride improves dermatitis score and inhibits scratch behavior in NC/Nga mice. Int Arch Allergy Immunol 153:121–132
Spergel JM, Mizoguchi E, Brewer JP et al (1998) Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J Clin Invest 101:1614–1622
Wang LF, Lin JY, Hsieh KH et al (1996) Epicutaneous exposure of protein antigen induces a predominant Th2-like response with high IgE production in mice. J Immunol 156:4077–4082
Spergel JM, Mizoguchi E, Oettgen H et al (1999) Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis. J Clin Invest 103:1103–1111
Akdis CA, Akdis M, Bieber T et al (2006) Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL consensus report. J Allergy Clin Immunol 118:152–169
Ohsawa Y, Hirasawa N (2014) The role of histamine H1 and H4 receptors in atopic dermatitis: from basic research to clinical study. Allergol Int 63:533–542
Rossbach K, Wendorff S, Sander K et al (2009) Histamine H4 receptor antagonism reduces hapten-induced scratching behaviour but not inflammation. Exp Dermatol 18:57–63
Seike M, Furuya K, Omura M et al (2010) Histamine H(4) receptor antagonist ameliorates chronic allergic contact dermatitis induced by repeated challenge. Allergy 65:319–326
Hirasawa N, Ohsawa Y, Katoh G et al (2009) Modification of the picryl chloride-induced allergic dermatitis model in mouse ear lobes by 12-O-tetradecanoylphorbol 13-acetate, and analysis of the role of histamine in the modified model. Int Arch Allergy Immunol 148:279–288
Cowden JM, Zhang M, Dunford PJ et al (2010) The histamine H4 receptor mediates inflammation and pruritus in Th2-dependent dermal inflammation. J Invest Dermatol 130:1023–1033
Kamo A, Negi O, Tengara S et al (2014) Histamine H(4) receptor antagonists ineffective against itch and skin inflammation in atopic dermatitis mouse model. J Invest Dermatol 134:546–548
Gutzmer R, Gschwandtner M, Rossbach K et al (2011) Pathogenetic and therapeutic implications of the histamine H4 receptor in inflammatory skin diseases and pruritus. Front Biosci (Schol Ed) 3:985–994
Rossbach K, Schaper K, Kloth C et al (2016) Histamine H4 receptor knockout mice display reduced inflammation in a chronic model of atopic dermatitis. Allergy 71:189–197
Wakasugi N, Tomita T and Kondo K (1967) Differences of fertility in reciprocal crosses between inbred strains of: DDK, KK and NC. J. Reprod. Fert. 13: 41–50
Yanaba K, Kamata M, Asano Y et al (2013) CD19 expression in B cells regulates atopic dermatitis in a mouse model. Am J Pathol 182:2214–2222
Cowden JM, Yu F, Challapalli M et al (2013) Antagonism of the histamine H4 receptor reduces LPS-induced TNF production in vivo. Inflamm Res 62:599–607
Thurmond RL, Desai PJ, Dunford PJ et al (2004) A potent and selective histamine H4 receptor antagonist with anti-inflammatory properties. J Pharmacol Exp Ther 309:404–413
McClain RW, Yentzer BA, Feldman SR (2009) Comparison of skin concentrations following topical versus oral corticosteroid treatment: reconsidering the treatment of common inflammatory dermatoses. J Drugs Dermatol 8:1076–1079
Neumann D, Schneider EH, Seifert R (2014) Analysis of histamine receptor knockout mice in models of inflammation. J Pharmacol Exp Ther 348:2–11
Novak N, Bieber T (2003) Allergic and nonallergic forms of atopic diseases. J Allergy Clin Immunol 112:252–262
Laske N, Niggemann B (2004) Does the severity of atopic dermatitis correlate with serum IgE levels? Pediatr Allergy Immunol 15:86–88
Dahten A, Koch C, Ernst D et al (2008) Systemic PPARgamma ligation inhibits allergic immune response in the skin. J Invest Dermatol 128:2211–2218
Leung DY, Bieber T (2003) Atopic dermatitis. Lancet 361:151–160
Matsuda H, Watanabe N, Geba GP et al (1997) Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol 9:461–466
Bäumer W, Seegers U, Braun M et al (2004) TARC and RANTES, but not CTACK, are induced in two models of allergic contact dermatitis. Effects of cilomilast and diflorasone diacetate on T-cell-attracting chemokines. Br J Dermatol 151:823–830
Van den Broeck W, Derore A, Simoens P (2006) Anatomy and nomenclature of murine lymph nodes: descriptive study and nomenclatory standardization in BALB/cAnNCrl mice. J Immunol Methods 312:12–19
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Roßbach, K., Köchling, H., Fukuyama, T., Wilzopolski, J., Kietzmann, M., Bäumer, W. (2017). Assessment of the Efficacy of Histamine Receptor Antagonists in Murine Models of Atopic Dermatitis. In: Tiligada, E., Ennis, M. (eds) Histamine Receptors as Drug Targets. Methods in Pharmacology and Toxicology. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6843-5_9
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6843-5_9
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6841-1
Online ISBN: 978-1-4939-6843-5
eBook Packages: Springer Protocols